Abstract:Our previous work revealed that Nrf1αexerts a tumor-repressing effect because its genomic loss (to yieldNrf1α-/-) results in oncogenic activation of Nrf2 and target genes. Interestingly,β-catenin is concurrently activated by loss of Nrf1αin a way similar toβ-catenin-driven liver tumor. However, a presumable relationship between Nrf1 andβ-catenin is not yet established. Here, we demonstrate that Nrf1 enhanced ubiquitination ofβ-catenin for targeting proteasomal degradation. Conversely, knockdown of Nrf1 by its short hairpin RNA (shNrf1) caused accumulation ofβ-catenin so as to translocate the nucleus, allowing activation of a subset of Wnt/β-catenin signaling responsive genes, which leads to the epithelial-mesenchymal transition (EMT) and related cellular processes. Such silencing of Nrf1 resulted in malgrowth of human hepatocellular carcinoma, along with malignant invasion and metastasis to the lung and liver in xenograft model mice. Further transcriptomic sequencing unraveled significant differences in the expression of both Wnt/β-catenin-dependent and Wnt/β-catenin-independent responsive genes implicated in the cell process, shape, and behavior of the shNrf1-expressing tumor. Notably, we identified thatβ-catenin is not a target gene of Nrf1, but this CNC-bZIP factor contributes to differential or opposing expression of other critical genes, such asCDH1,Wnt5A,Wnt11A,FZD10,LEF1,TCF4,SMAD4,MMP9,PTEN,PI3K,JUN, andp53, each of which depends on the positioning of distinctcis-regulatory sequences (e.g., ARE and/or AP-1 binding sites) in the gene promoter contexts. In addition, altered expression profiles of some Wnt/β-catenin signaling proteins were context dependent, as accompanied by decreased abundances of Nrf1 in the clinic human hepatomas with distinct differentiation. Together, these results corroborate the rationale that Nrf1 acts as abona fidedominant tumor repressor, by its intrinsic inhibition of Wnt/β-catenin signaling and relevant independent networks in cancer development and malignant progression.

Construction of Human LDHA Gene Promoter Plasmid and Analysis of Its Transcriptional Regulation and Function by Nrf2 in Lung Cancer Cells

Genome-wide Global Identification of NRF2 Binding Sites in A549 Non-Small Cell Lung Cancer Cells by ChIP-Seq Reveals NRF2 Regulation of Genes Involved in Focal Adhesion Pathways

Luteolin Inhibits Nrf2 Leading to Negative Regulation of the Nrf2/Are Pathway and Sensitization of Human Lung Carcinoma A549 Cells to Therapeutic Drugs

Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer: from bedside to bench

“NRF2 Addiction” in Lung Cancer Cells and Its Impact on Cancer Therapy

Knockdown Of Lactate Dehydrogenase A Suppresses Tumor Growth And Metastasis Of Human Hepatocellular Carcinoma

Construction and Functional Analysis of Luciferase Reporter Plasmid Containing NF-H Gene Promoter

LDHA Promotes Tumor Metastasis by Facilitating Epithelial-Mesenchymal Transition in Renal Cell Carcinoma

Inhibition of LDHA Deliver Potential Anticancer Performance in Renal Cell Carcinoma.

Construction and Functional Analysis of Luciferase Reporter Plasmid Containing PCNA Gene Promoter

Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma

Identifying the critical oncogenic mechanism of LDHA based on a prognostic model of T-cell synthetic drivers

Promotion of cell autophagy and apoptosis in cervical cancer by inhibition of long noncoding RNA LINC00511 via transcription factor RXRA-regulated PLD1.

The Function of Nrf2 in Metabolic Regulation and Its Role in Tumor Growth and Proliferation

Construction and Functional Analysis of Luciferase Reporter Plasmids Containing ATM and ATR Gene Promoters

Regulating the Expression of HIF-1α or lncRNA: Potential Directions for Cancer Therapy

Nuclear factor erythroid 2 (NF-E2)-related factor 2 (Nrf2) in non-small cell lung cancer

Construction of FasL Sirna Expression Vector and Its Expression in Lung Cancer Cell Line A549

Nrf1 is Endowed with a Dominant Tumor-Repressing Effect Onto the Wnt/β-Catenin-Dependent and Wnt/β-Catenin-Independent Signaling Networks in the Human Liver Cancer

Proteomic identification of the lactate dehydrogenase A in a radioresistant prostate cancer xenograft mouse model for improving radiotherapy.

LINC00908 promotes malignant progression and glycolysis in lung adenocarcinoma via interactions with DDX54 and RFX2